Paxil Birth Defect Lawsuit Settlements Reach $1 Billion
GlaxoSmithKline, the manufacturer of Paxil, has reportedly agreed to settle some 800 Paxil birth defect lawsuits for the sum of $1 billion. The Paxil settlements will pay individual families approximately $1.2 million.
The remaining 100 Paxil lawsuits include three that are set for trial later this year in Philadelphia.
Paxil is a controversial anti-depressant drug that has been linked to birth defects in pregnant mothers who were taking the drug. Such birth defects include cardiac problems and pulmonary hypertension.
Latest posts by Jared Green (see all)
- A Plaintiff’s Prior Negligence is Not Admissible to Establish Contributory Negligence - November 7, 2024
- Jury Awards $7.1 Million to Pennsylvania Woman for Missed Blood Clot - October 7, 2024
- Does a Plaintiff’s Suicide Bar His or Her Estate from Recovering Damagesin a Medical Malpractice Case? - August 7, 2024